Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia

被引:26
作者
Souverein, Olga W.
Defesche, Joep C.
Zwinderman, Aeilko H.
Kastelein, John J. P.
Tanck, Michael W. T.
机构
[1] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 DE Amsterdam, Netherlands
[2] Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands
关键词
cardiovascular disease; LDL-receptor mutations; familial hypercholesterolaemia; age of onset; frailty model;
D O I
10.1093/eurheartj/ehl366
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Aims To investigate the influence of different LDL-receptor (LDLR) gene mutations on age at first cardiovascular event in familial hypercholesterolaemia (FH) patients. Methods and results Dutch FH patients (n = 862) with known LDLR mutations from a retrospective cohort study were included. A gamma frailty Cox model was used. An event was defined as the first cardiovascular event. Gender, hypertension, smoking, diabetes, HDL cholesterol, LDL cholesterol (LDL-C), or triglycerides were included as covariates. Furthermore, the effect of LDLR mutation type on LDL and HDL cholesterol levels was investigated using mixed effects models, including gender, smoking, body mass index, and age at time of lipid measurement as covariates. A total of 86 different LDLR mutations were present in this cohort. Twenty-two percent of patients experienced an event (median age: 47.1 year; range: 25.6-85.8 years). The effect of LDLR mutation type on event-free survival is only significant in the models without LDL-C levels. Also, LDLR mutation type was significantly associated with LDL-C levels (P = 0.007), but not with HDL cholesterol levels (P = 0.12). Conclusion In the present study, LDL-C levels are a more important risk factor of event-free survival than the type of LDLR mutation.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 34 条
[1]
Antonarakis SE, 1998, HUM MUTAT, V11, P1
[2]
Familial hypercholesterolemia and coronary heart disease: A HuGE association review [J].
Austin, MA ;
Hutter, CM ;
Zimmern, RL ;
Humphries, SE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (05) :421-429
[3]
Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype [J].
Bertolini, S ;
Cantafora, A ;
Averna, M ;
Cortese, C ;
Motti, C ;
Martini, S ;
Pes, G ;
Postiglione, A ;
Stefanutti, C ;
Blotta, I ;
Pisciotta, L ;
Rolleri, M ;
Langheim, S ;
Ghisellini, M ;
Rabbone, I ;
Calandra, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (09) :E41-E52
[4]
Influence of genetic variability in the nondeletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a 'null' LDL-receptor gene defect [J].
Betard, C ;
Kessling, AM ;
Roy, M ;
Davignon, J .
ATHEROSCLEROSIS, 1996, 119 (01) :43-55
[5]
A Double Mutant [N543H+2393del9] Allele in the LDL Receptor Gene in Familial Hypercholesterolemia: Effect on Plasma Cholesterol Levels and Cardiovascular Disease [J].
Castillo, S. ;
Reyes, G. ;
Tejedor, D. ;
Mozas, P. ;
Suarez, Y. ;
Lasuncion, M. A. ;
Cenarro, A. ;
Civeira, F. ;
Alonso, R. ;
Mata, P. ;
Pocovi, M. .
HUMAN MUTATION, 2002, 20 (06) :477
[6]
Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population:: Influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol [J].
Chaves, FJ ;
Real, JT ;
García-García, AB ;
Civera, M ;
Armengod, ME ;
Ascaso, JF ;
Carmena, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4926-4932
[7]
Detection of large deletions in the LDL receptor gene with quantitative PCR methods [J].
Damgaard, D ;
Nissen, PH ;
Jensen, LG ;
Nielsen, GG ;
Stenderup, A ;
Larsen, ML ;
Faergeman, O .
BMC MEDICAL GENETICS, 2005, 6
[8]
den Dunnen JT, 2000, HUM MUTAT, V15, P7
[9]
CORONARY-ARTERY DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITH THE SAME LDL RECEPTOR GENE MUTATION [J].
FERRIERES, J ;
LAMBERT, J ;
LUSSIERCACAN, S ;
DAVIGNON, J .
CIRCULATION, 1995, 92 (03) :290-295
[10]
Update of the molecular basis of familial hypercholesterolemlia in The Netherlands [J].
Fouchier, SW ;
Kastelein, JJP ;
Defesche, JC .
HUMAN MUTATION, 2005, 26 (06) :550-556